Science guides everything we do

Your brain is important to us

(We imagine it's pretty important to you, too)

Neuroscience research has uncovered how malleable the brain is, even for people with genetic markers for dementia and Alzheimer's disease. New scientific evidence reveals how targeted lifestyle changes can benefit brain health both now and in the future.

Neurotrack's clinically-validated cognitive screening tools are designed to help individuals assess, monitor, and strengthen their brain health over time.

The science behind our cognitive assessments

Eye tracking reveals insight into cognitive function

Our eye-tracking technology uses the camera on your mobile device

Neurotrack's team of neuroscientists, neuropsychologists, and engineers have developed a clinically-validated suite of cognitive assessments that leverage haptic and eye-tracking technology. These digital assessments, taken regularly and over time, can serve as an early detection tool for identifying cognitive changes early.

Our technology builds on the groundbreaking research of renowned neuroscientist and Neurotrack's co-founder, Dr. Stuart Zola, whose breakthrough clinical study on Alzheimer's disease showed that eye movements, tracked through a camera, reveal important data about the state of our cognitive health and its potential for decline in the future.

What do Neurotrack's assessments measure?

Our assessments measure multiple cognitive domains (and the brain has many!) and provide a detailed report of one's cognitive condition.

Processing Speed

The rate at which you take in new information, reach judgment on it, and formulate a response. For example, seeing a car run a light and responding by slamming on the brakes.

Recognition Memory

The ability to recognize previously encountered events, objects, or people. When you see a face at a coffee shop and remember it’s the guy who sat behind you in high school geometry, that’s recognition memory.

Associative Learning

The process of learning the link between items and concepts. Some examples are learning a new coworker's name, or learning that the sound of a siren means an emergency vehicle is near.

Associative Memory

Related to Associative Learning, this is the ability to remember the relationship between items. For example, smelling smoke and knowing that something must be burning on the stove, or walking down your street and knowing that this is where you live.


Your ability to control your thoughts and actions. For example, not looking at your phone while you are getting important work done, or stopping yourself from eating that second slice of chocolate cake.


Your ability to process information.

Examples include listening to your partner in a restaurant while ignoring everyone else (selective attention), watching a movie (sustained attention), talking to a passenger while driving (divided attention), or reading a recipe and cooking a meal (alternating attention).

Executive Function

Your ability to get tasks done. Planning a vacation, organizing household items, switching your thoughts from one task on your to-do list to another are all examples of executive function.

The science behind our Cognitive Health Program

The FINGER study

The FINGER study (The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) was a multi-year study of 1,200 adults at risk for cognitive decline. People who engaged in a multi-domain lifestyle intervention, including diet, exercise, and cognitive training, demonstrated improved cognitive performance.

This landmark study provides strong scientific evidence that targeted intervention can positively impact cognition over time – even in people who are at risk for decline. The FINGER study has been adapted on a global scale, with clinical studies taking place in multiple countries. Read more about World Wide FINGERS.

Overall Improvement

Executive Function

Processing Speed

The Neurotrack Cognitive Health Program

Our Cognitive Health Program is modeled after the multi-domain intervention that was proven to be effective in the FINGER study. Six lifestyle-related domains are included in our program, all of which are considered modifiable risk factors for dementia and Alzheimer's.

Stress management

Social engagement


Cognitive training



A year-long Phase 1 trial of the Neurotrack Cognitive Health Program demonstrated improvements in cognitive function, relief from depression, and a reduction in anxiety among older adults who were at-risk of cognitive impairment.

Neurotrack is always investing in its clinical research. In 2019, the company received a $3.3 million grant from the National Institute on Aging, a division of the U.S. National Institutes of Health, to conduct a Phase II trial to further validate Neurotrack’s Cognitive Health Program.

This research, the Digital Cognitive Multi-domain Alzheimer's Risk Velocity (DC MARVel) led by Dr. Michelle Gray, is underway at the University of Arkansas. The protocol for this randomized controlled trial was published in JMIR Research Protocols in February 2022.

There is no cure, but you can reduce your risk

Currently, there is no cure for dementia-related diseases like Alzheimer's. Clinical trials in the past two decades have seen numerous failures with only a handful of drugs approved for Alzheimer's treatment1. The majority of these FDA-approved drugs only treat the symptoms of the disease2 and the most recently approved medication that aims to modify disease progression is highly controversial and has unclear efficacy3.

So, what can you do?

It's not rocket science, but it is brain science. Neurotrack invests in and leverages the latest neuroscience research to deliver convenient, digital solutions to help businesses and individuals better manage their cognitive health for customers and themselves.

1. Stone, G. (2018). Researching Alzheimer’s medicines: Setbacks and stepping stones. Retrieved from Alzheimer’s Disease International website:

2. Mayo Clinic. (2019, April 19). Alzheimer's: Drugs help manage symptoms. Retrieved from

3. Park, A. Law, T. (2021, August 5). Inside the controversy around Biogen's Alzheimer's drug. Retrieved from

We're dedicated to clinical research

2022 Campitelli

Effect of Health Coaching and Education on Cognition


Health coaching and education can both improve cognition, but coaching may be more effective and may yield increased protection against ADRD risk.


2022 Gray

DC MARVel Protocol for Randomized Trial

JMIR Research Protocols

The intervention in the Digital, Cognitive, Multi-domain Alzheimer Risk Velocity is uniquely designed to reduce the risk of AD through a web-based health coaching experience that addresses the modifiable lifestyle-based risk factors.


2022 Myers

Reliability of Neurotrack Cognitive Battery

JMIR Formative Research

There is an urgent, growing need for remote cognitive assessment for individuals with cognitive impairment. The Neurotrack Cognitive Battery (NCB) is a brief, easy-to-administer, and reliable assessment for remote cognitive testing.


2021 Sverdlov

Technologies to Characterize Depression

Frontiers in Psychiatry

This study provides preliminary estimates of classification accuracy of the digital technologies and describes digital biomarkers that could be useful for characterizing unipolar depression.


2021 Gray

Cognitive Management in a Digital World


Invited editorial about the diagnosis, treatment, and prevention of cognitive decline via digital intervention.


2021 Gills

Arginine Silicate and Cognitive Outcomes


Supplementation with inositol-stabilized arginine silicate (ASI) helped young adults improve performance on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).


2021 Madero

Distractions During Digital Cognitive Assessment

The Journal of Prevention of Alzheimer's Disease

This retrospective study analyzed the frequency of and factors associated with environmental distractions during a brief digital assessment taken at home. A total of 7.4% of test administrations included distractions.


2020 Gray

Cognitive Decline Impacts Physical Function

Experimental Gerontology

Significant correlations existed between measures of memory and physical function suggesting a positive relationship between physical function and cognitive status.


2020 McGurran

Diet and Risk Reduction of Alzheimer's Disease

Current Alzheimer Research

In this review, we summarize some of the biological mechanisms of key compounds in their relation to AD and how they fit into a dietary pattern that supports the role of diet as a risk reducing factor for AD.


2019 Gills

Digital Eye-Tracking Predicts Cognitive Status


A five-minute, digital version of the visual paired comparison task successfully predicts cognitive outcomes. This is a less burdensome and more scalable assessment, enabling longitudinal monitoring of cognitive status in resource-limited environments.


2019 Bott

Multidomain Interventions and Cognitive Health


The review presented here by Neurotrack’s scientific team covers completed and upcoming studies that use multi-domain lifestyle interventions to promote cognitive health and decrease the risk of Alzheimer’s Disease and related dementias. These include the upcoming World-Wide FINGERS studies and a number of studies supported by digital intervention strategies.


2019 Glenn

Multimodal Digital Cognitive Health Platform in Japan

JMIR MHealth and UHealth

This paper details the cross-cultural feasibility of the Neurotrack platform in a Japanese population. Similar to previous literature, platform engagement metrics were highly correlated, with greater engagement shown to relate to increased participation in healthy lifestyle behaviors.


2019 Glenn

Protein and Amino Acid Maintenance


There is an abundant amount of proteins and amino acids in our regular diet, and regular consumption is linked to a number of disease-related risk factors for Alzheimer’s Disease and related dementias. This review by Neurotrack’s scientific team covers the preventative roles regular proteins and amino acids play, as well as makes recommendations on proper intake to decrease risk of cognitive decline.


2019 McGurran

Exercise and AD Review

Journal of Alzheimer’s Disease

Exercise is known to be beneficial to the brain and cardiovascular system. This review paper summarizes what is currently known about the relationship between exercise and Alzheimer’s disease.


2019 Gills

5 Minute Test Validation


This paper demonstrates the stability and reliability of Neurotrack’s 5-minute eye tracking test. The test also correlates moderately with gold standard cognitive composites and Neurotrack’s 30-minute eye tracking test.


2019 Bott

Scoring Algorithm Validation

Telemedicine and e-Health

This paper validates the use of Neurotrack’s proprietary algorithm for scoring eye tracking data. Study participants completed the Neurotrack 5-minute eye tracking test on 3 separate occasions while being simultaneously recorded by a webcam and a research-grade eye tracking camera. The data was equivalent across camera types and scoring modalities.


2018 Kumar

Pilot Study Results

JMIR Aging

This paper details the results of the VC Health study, a pilot study on the Cognitive Health Program. Over 80 older adults with subjective memory decline enrolled in the study and were given access to the Cognitive Health Program. After one year, participants experienced significant improvements in cognitive function, anxiety, and depression.


2018 Bott

Pilot Study Protocol

JMIR Research Protocols

This paper details the protocol and baseline characteristics of the participants in the VC Health study, a pilot study on the Cognitive Health Program. A total of 82 adults age 60-75 with subjective memory complaints enrolled in the year-long study and used the program.


2018 Bott

30 Minute Test Validation

Journal of Medical Internet Research

This study demonstrated modest correlations between Neurotrack’s 30-minute eye tracking test and gold-standard cognitive assessments known to be sensitive to early signs of decline. The data supports the use of eye tracking tests that utilize device-embedded cameras to provide efficient and scalable evaluation of cognitive performance.


2017 Bott

Webcam Validation

Frontiers in Neuroscience

This study validated the use of standard webcams in place of expensive research-grade eye tracking cameras for one of Neurotrack’s eye tracking tests. This data supports the scalability of Neurotrack’s tests, as no special equipment is required except a laptop, tablet, or smartphone with a webcam.